Original Research
Published on 30 Sep 2020
Clinical Outcomes for PD-1 Inhibitor Plus Chemotherapy as Second-Line or Later Therapy Compared to PD-1/PD-L1 Inhibitor Alone in Advanced Non-small-cell Lung Cancer
in Thoracic Oncology
- 4,160 views
- 6 citations